China National Medicines Corp - Stock

China National Medicines Corp P/E 2024

China National Medicines Corp P/E

10.7

Ticker

600511.SS

ISIN

CNE000001D56

As of Jun 30, 2024, China National Medicines Corp's P/E ratio was 10.7, a -18.94% change from the 13.2 P/E ratio recorded in the previous year.

The China National Medicines Corp P/E history

China National Medicines Corp Aktienanalyse

What does China National Medicines Corp do?

China National Medicines Corp ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering China National Medicines Corp's P/E Ratio

The Price to Earnings (P/E) Ratio of China National Medicines Corp is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing China National Medicines Corp's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of China National Medicines Corp is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in China National Medicines Corp’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about China National Medicines Corp Stock

What is the price-to-earnings ratio of China National Medicines Corp?

The price-earnings ratio of China National Medicines Corp is currently 10.7.

How has the price-earnings ratio of China National Medicines Corp changed compared to last year?

The price-to-earnings ratio of China National Medicines Corp has increased by -18.94% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of China National Medicines Corp high compared to other companies?

Yes, the price-to-earnings ratio of China National Medicines Corp is high compared to other companies.

How does an increase in the price-earnings ratio of China National Medicines Corp affect the company?

An increase in the price-earnings ratio of China National Medicines Corp would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of China National Medicines Corp affect the company?

A decrease in the price-earnings ratio of China National Medicines Corp would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of China National Medicines Corp?

Some factors that influence the price-earnings ratio of China National Medicines Corp are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does China National Medicines Corp pay?

Over the past 12 months, China National Medicines Corp paid a dividend of 0.78 CNY . This corresponds to a dividend yield of about 2.54 %. For the coming 12 months, China National Medicines Corp is expected to pay a dividend of 0.86 CNY.

What is the dividend yield of China National Medicines Corp?

The current dividend yield of China National Medicines Corp is 2.54 %.

When does China National Medicines Corp pay dividends?

China National Medicines Corp pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of China National Medicines Corp?

China National Medicines Corp paid dividends every year for the past 23 years.

What is the dividend of China National Medicines Corp?

For the upcoming 12 months, dividends amounting to 0.86 CNY are expected. This corresponds to a dividend yield of 2.8 %.

In which sector is China National Medicines Corp located?

China National Medicines Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von China National Medicines Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China National Medicines Corp from 6/9/2023 amounting to 0.782 CNY, you needed to have the stock in your portfolio before the ex-date on 6/9/2023.

When did China National Medicines Corp pay the last dividend?

The last dividend was paid out on 6/9/2023.

What was the dividend of China National Medicines Corp in the year 2023?

In the year 2023, China National Medicines Corp distributed 0.7 CNY as dividends.

In which currency does China National Medicines Corp pay out the dividend?

The dividends of China National Medicines Corp are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China National Medicines Corp

Our stock analysis for China National Medicines Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China National Medicines Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.